Amphotericin B Colloidal Dispersion
PreclinicalSmall molecule
Amphotericin B Colloidal Dispersion is one of 3 small molecule programs targeting Cryptococcal Meningitis. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Cryptococcal Meningitis
#DrugCompanyPhaseTrials
1Sporanox
SSebela Pharmaceuticals Development LLC
Preclinical
Amphotericin B Deoxycholate
Merck & Co.Preclinical
Amphotericin B Colloidal Dispersion
PPeking Union Medical College Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details